Plasma adhesion molecules in children with sleep-disordered breathing

Chest

Volumn 129, Issue 4, 2006, Pages 947-953

  O'Brien, Louise M ^a   Serpero, Laura D ^a   Tauman, Riva ^a   Gozal, David ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

Adhesion molecules; Atherosclerosis; Sleep disordered breathing

Indexed keywords

C REACTIVE PROTEIN; CELL ADHESION MOLECULE; INTERCELLULAR ADHESION MOLECULE 1; PADGEM PROTEIN;

APNEA; AROUSAL; ARTICLE; BLOOD LEVEL; BODY MASS; CARDIOVASCULAR DISEASE; CHILD; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ACTIVITY; DISEASE SEVERITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OBESITY; OXYGEN SATURATION; POLYSOMNOGRAPHY; PRIORITY JOURNAL; PULSE OXIMETRY; RISK ASSESSMENT; SCORING SYSTEM; SLEEP DISORDERED BREATHING; STATISTICAL SIGNIFICANCE;

EID: 33646009688     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.129.4.947     Document Type: Article

References (62)

1. Young T, Peppard P, Palta M, et al. Population-based study of sleep-disordered breathing as a risk factor for hypertension. Arch Intern Med 1997; 157:1746-1752
2. Nieto FJ, Young T, Lind B, et al. Sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study. JAMA 2000; 283:1829-1836
3. Peppard PE, Young T, Palta M, et al. Prospective study of the association between sleep-disordered breathing and hypertension N Engl J Med 2000; 342:1378-1384
4. Mooe T, Franklin KA, Holmstrom K, et al. Sleep-disordered breathing and coronary artery disease: long-term prognosis. Am J Respir Crit Care Med 2001; 164:1910-1913
5. Shahar E, Whitney CW, Redline S, et al. Sleep-disordered breathing and cardiovascular disease: cross-sectional results of the Sleep Heart Health Study. Am J Respir Crit Care Med 2001; 163:19-25
6. Ridker PM, Hennekens CH, Buring JE, et al. C reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 2000; 342:836-843
7. Ridker PM. High sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease. Circulation 2001; 103:1813-1818
8. Pasceri V, Willerson JT, Yeh ET. Direct proinflammatory effect of C-reactive protein on human endothelial cells. Circulation 2000; 102:2165-2168
9. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993; 362:801-809
10. Pober JS, Gimbrone MA, Lapiette LA, et al. Overlapping patterns of activation of human endothelial cells by interleukin-1, tumor necrosis factor, and immune interferon. J Immunol 1986; 137:1893-1896
11. Chin K, Nakamura T, Shimuzu K, et al. Effects of nasal continuous positive airway pressure on soluble cell adhesion molecules in patients with obstructive sleep apnea syndrome. Am J Med 2000; 109:562-567
12. El-Solh AA, Mador AJ, Sikka P, et al. Adhesion molecules in patients with coronary artery disease and moderate-to-severe obstructive sleep apnea. Chest 2002; 121:1541-1547
13. Blann AD, McCollum CN. Increased soluble P-selectin in peripheral artery disease: a new marker for the progression of atherosclerosis [letter]. Thromb Haemost 1998; 80:1031-1032
14. Ridker PM, Buring JE, Rifai N. Soluble P-selectin and the risk of future cardiovascular events. Circulation 2001; 103:491-495
15. Aljadeff G, Gozal D, Schechtman VL, et al. Heart rate variability in children with obstructive sleep apnea. Sleep 1997; 20:151-157
16. Baharav A, Kotagel S, Rubin BK, et al. Autonomic cardiovascular control in children with obstructive sleep apnea. Clin Autonom Res 1999; 9:345-351
17. O'Brien LM, Gozal D. Autonomic dysfunction in children with sleep-disordered breathing. Sleep 2005; 28:747-752
18. Marcus CL, Greene MG, Carroll JL. Blood pressure in children with obstructive sleep apnea. Am J Respir Crit Care Med 1998; 157:1098-1103
19. Enright PL, Goodwin JL, Sherrill DL, et al. Blood pressure elevation associated with sleep-related breathing disorder in a community sample of white and Hispanic children: the Tuscon Children's Assessment of Sleep Apnea Study. Arch Pediatr Adolesc Med 2003; 157:901-904
20. Kohyama J, Ohinata JS, Hasegawa T. Blood pressure in sleep disordered breathing. Arch Dis Child 2003; 88:139-142
21. Amin RS, Carroll JL, Jeffries JL, et al. Twenty-four-hour ambulatory blood pressure in children with sleep-disordered breathing. Am J Respir Crit Care Med 2004; 169:950-956
22. Amin RS, Kimball TR, Bean JA, et al. Left ventricular hypertrophy and abnormal ventricular geometry in children and adolescents with obstructive sleep apnea. Am J Respir Crit Care Med 2002; 165:1395-1399
23. Amin RS, Kimball TR, Kalra M, et al. Left ventricular function in children with sleep-disordered breathing. Am J Cardiol 2005; 95:801-804
24. Tauman R, Ivanenko A, O'Brien LM, et al. Plasma C-reactive protein in children with sleep-disordered breathing. Pediatrics 2004; 113:e564
25. Kaditis AG, Alexopoulos EI, Kalampouka E, et al. Morning levels of C-reactive protein in children with obstructive sleep-disordered breathing. Am J Respir Crit Care Med 2005; 171:282-286
26. Rechtschaffen A, Kales A. A manual of standardized terminology, techniques and scoring systems for sleep stages of human subject. Washington, DC: National Institutes of Health. 1968; publication No. 204
27. Sleep Disorders Atlas Task Force. Guilleminault C, ed. EEG arousals: scoring and rules and examples. Sleep 1992; 15:173-184
28. Mograss MA, Ducharme FM, Brouillette RT. Movement/arousals: description, classification, and relationship to sleep apnea in children. Am J Respir Crit Care Med 1994; 150:1690-1696
29. Marcus CL, Omlin KJ, Basinki DJ, et al. Normal polysomnographic values for children and adolescents. Am Rev Respir Dis 1992; 156:1235-1239
30. American Thoracic Society. Standards and indications for cardiopulmonary sleep studies in children. Am J Respir Crit Care Med 1996; 153:866-878
31. Hammer LD, Kraemer HC, Wilson DM, et al. Standardized percentile curves of body-mass index for children and adolescents. Am J Dis Child 1991; 145:259-263
32. Bokinsky G, Miller M, Ault K, et al. Spontaneous, platelet activation and aggregation during obstructive sleep apnea and its response to therapy with nasal continuous positive airway pressure: a preliminary investigation. Chest 1995; 108:625-630
33. Eisensehr I, Ehrenberg BL, Noachtar S, et al. Platelet activation, epinephrine, and blood pressure in obstructive sleep apnea syndrome. Neurology 1998; 51:188-195
34. Ohga E, Nagase T, Tomita T, et al. Increased levels of circulating ICAM-1, VCAM-1, and L-selectin in obstructive sleep apnea syndrome. J Appl Physiol 1999; 87:10-14
35. Sanner BM, Konermann M, Tepel M, et al. Platelet function in patients with obstructive sleep apnoea syndrome. Eur Respir J 2000; 16:648-652
36. Geiser T, Buck F, Meyer BJ, et al. In vivo platelet activation is increased during sleep in patients with obstructive sleep apnea syndrome. Respiration 2002; 69:229-234
37. Von Kanel R, Dimsdale J. Hemostatic alterations in patients with obstructive sleep apnea and the implications for cardiovascular disease. Chest 2003; 124:1956-1967
38. Hui DS, Ko FW, Fok JP, et al. The effects of nasal CPAP on platelet activation in obstructive sleep apnea syndrome. Chest 2004; 125:1768-1775
39. Olson LJ, Olson EJ, Somers VK. Obstructive sleep apnea and platelet activation: another potential link between sleep-disordered breathing and cardiovascular disease. Chest 2004; 126:339-341
40. Jennum P, Wildschiodtz G, Christensen NJ, et al. Blood pressure, catecholamines, and pancreatic polypeptide in obstructive sleep apnea with and without nasal continuous positive airway pressure (nCPAP) treatment. Am J Hypertens 1989; 2:847-852
41. Lavie L, Vishnevsky A, Lavie P. Evidence for lipid peroxidation in obstructive sleep apnea. Sleep 2004; 27:123-128
42. Schulz R, Mahmoudi S, Hattar K, et al. Enhanced release of superoxide from polymorphonuclear neutrophils in obstructive sleep apnea: impact of continuous positive airway pressure therapy. Am J Respir Crit Care Med 2000; 162:566-570
43. Lavie L. Sleep apnea syndrome, endothelial dysfunction, and cardiovascular morbidity. Sleep 2004; 27:1053-1055
44. Lavie L. Obstructive sleep apnoea syndrome: an oxidative stress disorder. Sleep Med Rev 2003; 7:35-51
45. Inwald DP, Kirkham FJ, Peters MJ, et al. Platelet and leucocyte activation in childhood sickle cell disease: association with nocturnal hypoxaemia. Br J Haematol 2000; 111:474-481;
46. erratum: Br J Haematol 2001; 112:1091
47. Setty BN, Stuart MJ, Dampier C, et al. Hypoxaemia in sickle cell disease: biomarker modulation and relevance to pathophysiology. Lancet 2003; 362:1450-1455
48. Ponthieux A, Herbeth B, Droesch S, et al. Biological determinants of serum ICAM-1, E-selectin, P-selectin and L-selectin levels in healthy subjects: the Stanislas study. Atherosclerosis 2004; 172:299-308
49. Robinson GV, Pepperell JC, Segal HC, et al. Circulating cardiovascular risk factors in obstructive sleep apnoea: data from randomised controlled trials. Thorax 2004; 59:777-782
50. Gallistl S, Sudi KM, Borkenstein M, et al. Correlation between cholesterol, soluble P-selectin, and D-dimer in obese children and adolescents. Blood Coagul Fibrinol 2000; 11:755-760
51. Nash MC, Wade AM, Shah V, et al. Normal levels of soluble E-selectin, soluble intercellular adhesion molecule-1 (sICAM-1), and soluble vascular cell adhesion molecule-1 (sVCAM-1) decrease with age. Clin Exp Immunol 1996; 103:167-170
52. Sack U, Burkhardt U, Borte M, et al. Age-dependent levels of select immunological mediators in sera of healthy children. Clin Diag Lab Immunol 1998; 5:28-32
53. Price DT, Loscalzo J. Cellular adhesion molecules and atherogenesis. Am J Med 1999; 107:85-97
54. Lagrand WK, Niessen HW, Nijmeijer R, et al. Role for complement as an intermediate between C-reactive protein and intercellular adhesion molecule-1 expression? Circulation 2001; 104:E46
55. Blann AD, Steele C, McCollum CN. The influence of smoking on soluble adhesion molecules and endothelial cell markers. Thromb Res 1997; 85:433-438
56. Ridker PM, Hennekens CH, Roitman-Johnson B, et al. Plasma concentration of soluble intercellular adhesion molecule 1 and risks of future myocardial infarction in apparently healthy men. Lancet 1998; 351:88-92
57. Bonetti PO, Lerman LO, Lerman A: Endothelial dysfunction: a marker of atherosclerotic risk. Arterioscler Thromb Vasc Biol 2003; 23:168-175
58. Halcox JP, Deanfield JE. Endothelial cell function testing: how does the method help us in evaluating vascular status? Acta Paediatr Suppl 2004; 93:48-54
59. Spence JD, Hegele RA. Non-invasive assessment of atherosclerosis risk. Curr Drug Targets Cardiovasc Haematol Disord 2004; 4:125-128
60. Kadotani H, Kadotani T, Young T, et al. Association between apolipoprotein E e4 and sleep-disordered breathing in adults. JAMA 2001; 285:2888-2890
61. Srinivasan SR, Ehnholm C, Wattigney WA, et al. The relation of apolipoprotein E polymorphism to multiple cardiovascular risk in children: the Bogalusa Heart Study. Atherosclerosis 1996; 123:33-42
62. Conklin DJ, Gozal D, Row BW, et al. Effect of chronic intermittent hypoxia on atherosclerosis in apoE-null mice: role of dyslipidemia [abstract]. FASEB J 2005; 19:abstract 387.4